One hundred old led by national medicine research and development of science and technology major projects
 
 
On October 20, 2014 08:48 

 
Source: journal of science and technology 

        On September 19, one hundred by guizhou old Johnson cheung pharmaceutical lead to organize the implementation of national major drug discovery "twelfth five-year" science and technology major projects - "national medicine product r&d and technology to promote" project in guiyang. 
 
        All nationalities in our country in the process of struggle against the disease, to maintain survival, with their living environment, natural resources, national culture as the foundation, created a variety of national characteristics of medical system, inheriting the development of a batch of major disease of refractory has the unique curative effect of secret recipe, prescription, formed a treasure of traditional Chinese medicine. With modern scientific idea and technology to raise the nation's level and capacity of traditional medicine, is one of the important strategic national innovation development of medicine industry. 
 
        Launched the "national medicine product r&d and technology to promote" special, by a nationwide selection "miao medicine stilbene glue up white capsule technical transformation, and then evaluation research" big "medicine varieties firments XiaoTong adminstration of post-marketing systemic evaluation", "Tibetan medicines to treat liver disease innovation 10 flavour gan ning granules of preclinical studies" "rheumatoid drug resistance cold moisture spread industrialization and Ⅳ clinical research", four unique ethnic medicine curative effect of product research and development project. Project is mainly composed of guiyang Johnson auspicious pharmaceutical company, the leader of Tibet Tibetan medicine company dew, Tibet and xinjiang Jin Shikang pharmaceutical company to undertake, at the same time with China institute of traditional Chinese medicine academy of sciences, zhejiang university, central south university for nationalities, guiyang college of traditional Chinese medicine, China tibetology research center, xinjiang institute of traditional Chinese medicine, etc. 
 
        According to introducing, the special total about $76 million, including enterprise investment of 60 million yuan. Entity undertaking will be established through the industry-university-institute cooperation with advanced technology platform, using a variety of modern scientific new ideas, new methods, new technology, the treatment of specific diseases such as tumor and rheumatic pain, age-related diseases such as arthritis, hide, d native medicine in new drug research and development, technical innovation, quality standard, pharmacodynamics, safety study and post-marketing clinical evaluation studies, so as to improve enterprise's capacity for independent innovation in the field of national medicine and product competitiveness.